WFS1_HUMAN,A133T,0.525,Altered Disordered interface (Pr = 0.22 | P = 0.03); Loss of Pyrrolidone carboxylic acid at Q136 (Pr = 0.20 | P = 2.2e-03), ELME000333|ELME000336|PS00005,-
WFS1_HUMAN,F329I,0.756,Altered Transmembrane protein (Pr = 0.30 | P = 1.7e-04), ELME000148,-
WFS1_HUMAN,R818C,0.330,-,-,-
WFS1_HUMAN,M518I,0.815,Altered Transmembrane protein (Pr = 0.25 | P = 1.5e-03); Altered DNA binding (Pr = 0.15 | P = 0.04); Gain of Pyrrolidone carboxylic acid at Q520 (Pr = 0.06 | P = 0.03), None,-
WFS1_HUMAN,R611H,0.183,-,-,-
WFS1_HUMAN,A559T,0.414,-,-,-
